{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:23:54Z","timestamp":1740108234940,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00192-018-3806-0","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T04:15:16Z","timestamp":1541564116000},"page":"193-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Female Pelvic Medicine & Reconstructive Surgery (FPMRS) challenges on behalf of the collaborative research in pelvic surgery consortium (CoRPS): managing complicated cases series 2: management of urinary incontinence in a neurogenic patient"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-3458","authenticated-orcid":false,"given":"Doreen E.","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladin A.","family":"Yurteri-Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengiz","family":"Asatiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin A.","family":"Brennand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara L.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"issue":"2","key":"3806_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.juro.2015.03.107","volume":"194","author":"D Snow-Lisy","year":"2015","unstructured":"Snow-Lisy D, Yerkes E, Cheng E. Update on urological management of spina bifida from prenatal diagnosis to adulthood. J Urol. 2015;194(2):288\u201396.","journal-title":"J Urol"},{"issue":"9448","key":"3806_CR2","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(04)17445-X","volume":"364","author":"L Mitchell","year":"2004","unstructured":"Mitchell L, Adzick N, Melchionne J, Pasquariello P, Sutton L, Whitehead A. Spina bifida. Lancet. 2004;364(9448):1885\u201395.","journal-title":"Lancet"},{"issue":"10","key":"3806_CR3","doi-asserted-by":"publisher","first-page":"e48399","DOI":"10.1371\/journal.pone.0048399","volume":"7","author":"P Veenboer","year":"2012","unstructured":"Veenboer P, Bosch J, van Asbeck F, de Kort L. Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review. PLoS One. 2012;7(10):e48399.","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"3806_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-2008-1072411","volume":"10","author":"G McDonnell","year":"2000","unstructured":"McDonnell G, McCann J. Why do adults with spina bifida and hydrocephalus die? A clinic-based study. Eur J Pediatr Surg. 2000;10(Suppl 1):31\u20132.","journal-title":"Eur J Pediatr Surg"},{"issue":"3 Pt 1","key":"3806_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, St\u00f6hrer M, Kramer G, Schmid D, Gaul G, Hauri D. Botulinum-a toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? preliminary results. J Urol. 2000;164(3 Pt 1):692\u20137.","journal-title":"J Urol"},{"key":"3806_CR6","doi-asserted-by":"crossref","unstructured":"Peyronnet B, Even A, Capon G, de Seze M et al. Intradetrusor injections of botulinum toxin a in adult patients with spinal dysraphism. J Urol 2018.","DOI":"10.1016\/j.juro.2018.05.006"},{"issue":"6","key":"3806_CR7","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","volume":"187","author":"D Ginsberg","year":"2012","unstructured":"Ginsberg D, Gousse A, Keppenne V, et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol. 2012;187(6):2131\u20139.","journal-title":"J Urol"},{"issue":"4","key":"3806_CR8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"F Cruz","year":"2011","unstructured":"Cruz F, Herschorn S, Aliotta P, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60(4):742\u201350.","journal-title":"Eur Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-018-3806-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-018-3806-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-018-3806-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:10:44Z","timestamp":1573067444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-018-3806-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3806"],"URL":"https:\/\/doi.org\/10.1007\/s00192-018-3806-0","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"type":"print","value":"0937-3462"},{"type":"electronic","value":"1433-3023"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"15 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Erin Brennand is the principle investigator for a prospective cohort funded by Contura International and RCT by Boston Scientific: ClinicalTrials.gov Identifier: NCT02480231. No other authors have any disclosures or conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}